Kirsten A. Campbell

Combination of dociparstat sodium (DSTAT), a CXCL12/CXCR4 inhibitor, with azacitidine for the treatment of hypomethylating agent refractory AML and MDS.

F. Gao, P. Westervelt, J. Dipersio, 2021, Leukemia research.

Low O6‐methylguanine‐DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours

S. Clark, A. Gill, M. Burt, 2009, Clinical endocrinology.

The half‐lives of plasma free metanephrines

M. Doogue, M. Whiting, Kirsten A. Campbell, 2012, Clinical endocrinology.